Aveanna Healthcare (NASDAQ:AVAH) Hits New 52-Week High Following Analyst Upgrade

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) hit a new 52-week high on Friday after UBS Group raised their price target on the stock from $1.70 to $2.80. UBS Group currently has a sell rating on the stock. Aveanna Healthcare traded as high as $4.95 and last traded at $4.84, with a volume of 69779 shares traded. The stock had previously closed at $4.53.

Institutional Trading of Aveanna Healthcare

Several institutional investors have recently modified their holdings of the company. SG Americas Securities LLC lifted its position in shares of Aveanna Healthcare by 24.6% during the 4th quarter. SG Americas Securities LLC now owns 23,941 shares of the company’s stock valued at $64,000 after acquiring an additional 4,721 shares during the last quarter. Acadian Asset Management LLC lifted its holdings in shares of Aveanna Healthcare by 185.6% during the first quarter. Acadian Asset Management LLC now owns 29,385 shares of the company’s stock valued at $72,000 after purchasing an additional 19,096 shares during the last quarter. Bank of New York Mellon Corp boosted its position in shares of Aveanna Healthcare by 6.6% in the 2nd quarter. Bank of New York Mellon Corp now owns 149,761 shares of the company’s stock valued at $413,000 after purchasing an additional 9,243 shares during the period. Vanguard Group Inc. increased its stake in Aveanna Healthcare by 1.8% in the 1st quarter. Vanguard Group Inc. now owns 2,571,251 shares of the company’s stock worth $6,402,000 after purchasing an additional 44,970 shares in the last quarter. Finally, King Street Capital Management L.P. lifted its stake in Aveanna Healthcare by 50.6% during the fourth quarter. King Street Capital Management L.P. now owns 6,400,000 shares of the company’s stock valued at $17,152,000 after buying an additional 2,150,000 shares in the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.

Aveanna Healthcare Price Performance

The firm’s fifty day simple moving average is $3.11 and its 200 day simple moving average is $2.67. The company has a market capitalization of $954.20 million, a price-to-earnings ratio of -8.27 and a beta of 2.08.

Aveanna Healthcare (NASDAQ:AVAH) last posted its quarterly earnings data on Thursday, May 9th. The company reported ($0.05) EPS for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.01. The firm had revenue of $490.65 million during the quarter, compared to analyst estimates of $485.05 million. During the same period in the prior year, the business posted ($0.06) EPS. Equities research analysts forecast that Aveanna Healthcare Holdings Inc. will post -0.13 earnings per share for the current fiscal year.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.